retatrutide ly3437943 glp-1 gip glucagon is the triple-agonist shaking up metabolic medicine. Activates GLP-1, GIP, and receptors in one shot. Phase 2 results: 24% body weight lost in 48 weeks—nearly double semaglutide. Key edge? Retatrutide vs Tirzepatide & Semaglutide

Delaying Progression of Diabetes-Related Nephropathy: Slows kidney damage associated with chronic diabetes

Long-term success depends on adopting sustainable lifestyle habits, but many patients maintain their weight loss with proper guidance

Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose Popular weight-loss drugs may also help silence the cravings behind addiction, reducing risks across alcohol, nicotine, opioids, and other substances

"I think there's an awful lot of judgement around, 'take medication', 'don't take medication', and a lot of it comes back to this drive, this urge to lose weight

And they may have difficulties at school, at work, or in social situations

At New Look New Life, these treatments are medically supervised to help patients lose weight safely and effectively